Search for cancer therapies could be transformed by innovative technique
the ONA take:
Researchers based at the University of Illinois have now developed a technique to pinpoint novel, medically relevant products produced created by bacteria. Many companies have steered away from natural product discovery due to the difficulties developing new products, but using their new technique, the investigators quickly has success developing a novel product derived from soil bacteria. Soil bacteria has been historically a good source, as it produces antibiotics to repel competitors.
The investigators used genomics to screen the soil bacteria in their search for novel antibiotic products. As the screening takes place, compounds of interest are tagged for review. The tags add mass, allowing the researchers to detect the compounds via mass spectrometry. (The most popular method typically used to identify novel products is bioassay-guided isolation, which has the tendency to produce similar results on repeated trials by "rediscovering" the most active or abundant compounds to the exclusion of the rarer compounds, which go unnoticed.) The sensitivity of mass spectrometry allows for novel products present at lower abundance.
Research results was reported in the journal ACS Chemical Biology.
Search for new cancer therapies could be transformed by innovative technique
In a study reported in ACS Chemical Biology, University of Illinois researchers developed a new technique to quickly uncover novel, medically relevant products produced by bacteria.
Past techniques involved screening more than 10,000 samples to find a novel product, said principal investigator Doug Mitchell, assistant professor of chemistry and Institute for Genomic Biology (IGB) member.
Sign Up for Free e-newsletters
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- Age Not a Deterrent to Immunotherapy for Malignant Melanoma
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|